SEO URLwww.firestrike.ai/deals/pathai-roche-acquisition-2026
acquisitionAnnounced · May 11, 2026Digital Pathology and AI-powered technologySource · SpeculativeArticle · Factual
Roche acquires PathAI
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
PathAI
Boston, Massachusetts
Acquirer
Roche
Merger
Status
Announced
Roche agreed to acquire PathAI. Reported deal value: Undisclosed. Status: Announced. Sector: Digital Pathology and AI-powered technology. Target headquarters context: Boston, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-05-11. Figures and status may change as filings and press coverage update.
Roche plans to acquire US digital pathology company PathAI for up to USD 1bn
Deal timeline
Announced
May 11, 2026 · medwatch.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Digital Pathology and AI-powered technology. Figures and status may change as sources update.
Sources: medwatch.com · Primary article · FireStrike proprietary index